| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biological Sciences, Wayne State University, Detroit, Michigan 48202 [W. X., H. R. P.], and Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109 [I. M., R. F. T.]
We have shown previously that the urokinase-type plasminogen activator receptor (uPAR) physically associates with ß2 integrins on human leukocyte membranes. We now report that uPAR associates with certain members of the ß1 and ß3 integrin families expressed by a nonhematopoietic fibrosarcoma cell line (HT1080) when adherent to certain extracellular matrix molecules. Flow cytometry studies indicated that HT1080 cells expressed uPAR and ß1 and ß3 integrins. Double staining immunofluorescence was used to label uPAR and ß1 and ß3 integrins. The staining patterns of uPAR and ß1 integrins were strikingly similar when attached to fibronectin, laminin, or vitronectin but not polylysine-coated substrates. Resonance energy transfer (RET) between uPAR and ß1 integrins was observed, especially at focal adhesion plaques; this indicates that these molecules are within about 7 nm of each other on these cell membranes. uPAR and ß3 integrin coclustering and RET were also observed on tumor cells adherent to vitronectin but not to fibronectin, laminin, or polylysine-coated surfaces. Because N-acetyl-D-glucosamine was found previously to inhibit ß2 integrin-uPAR association, we tested the effect of saccharides on the ß1-uPAR and ß3-uPAR colocalization and RET. Colocalization and RET between uPAR and ß1 or ß3 integrins were effectively inhibited by N-acetyl-D-glucosamine on extracellular matrix-coated surfaces. To better define which members of ß1 and ß3 integrin families associate with uPAR, we studied the association of several
subunits with uPAR on tumor cells. We found that: (a)
5 colocalizes with uPAR on cells attached to fibronectin-coated surfaces; (b)
5 and
v colocalize with uPAR on cells adherent to vitronectin; and (c)
3 and
6 associate with uPAR on cells attached to laminin. In further support of physical associations between integrins and uPAR on tumor cells, uPAR was found to coimmunoprecipitate with ß1 integrins in Brij-58 lysates of HT1080 cells (as detected by anti-uPAR Western blotting of material isolated from an anti-ß1 integrin immunoaffinity column). Thus, uPAR may laterally associate with integrins of tumor cells when attached to specific extracellular matrix elements to enable directional proteolysis for tumor cell migration and invasion.
1 This work was supported by NIH Grant AI/CA27409 and the Research Stimulation Fund of Wayne State University (to H. R. P.) and NIH Grants CA39064 and CA42246 (to R. F. T.).
2 To whom requests for reprints should be addressed. Phone: (313) 577-2896; Fax: (313) 577-9008.
Received 9/16/96. Accepted 3/ 1/97.
This article has been cited by other articles:
![]() |
C.-H. Tang, M. L. Hill, A. N. Brumwell, H. A. Chapman, and Y. Wei Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with {beta}1 integrins J. Cell Sci., November 15, 2008; 121(22): 3747 - 3756. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Tang, A. Vararattanavech, and S.-M. Tan Urokinase-type Plasminogen Activator Receptor Induces Conformational Changes in the Integrin {alpha}M{beta}2 Headpiece and Reorientation of Its Transmembrane Domains J. Biol. Chem., September 12, 2008; 283(37): 25392 - 25403. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Smith, P. Marra, and C. J. Marshall uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180 J. Cell Biol., August 25, 2008; 182(4): 777 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hillig, L. H. Engelholm, S. Ingvarsen, D. H. Madsen, H. Gardsvoll, J. K. Larsen, M. Ploug, K. Dano, L. Kjoller, and N. Behrendt A Composite Role of Vitronectin and Urokinase in the Modulation of Cell Morphology upon Expression of the Urokinase Receptor J. Biol. Chem., May 30, 2008; 283(22): 15217 - 15223. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Garrigues, Y. E. Rubinchikova, C. M. DiPersio, and T. M. Rose Integrin {alpha}V 3 Binds to the RGD Motif of Glycoprotein B of Kaposi's Sarcoma-Associated Herpesvirus and Functions as an RGD-Dependent Entry Receptor J. Virol., February 1, 2008; 82(3): 1570 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. He, X.-d. Liu, Z.-y. Chen, J. Zhu, Y. Xiong, K. Li, J.-h. Dong, and X. Li Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis Clin. Cancer Res., June 1, 2007; 13(11): 3115 - 3124. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, C.-H. Tang, Y. Kim, L. Robillard, F. Zhang, M. C. Kugler, and H. A. Chapman Urokinase Receptors Are Required for {alpha}5beta1 Integrin-mediated Signaling in Tumor Cells J. Biol. Chem., February 9, 2007; 282(6): 3929 - 3939. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Gondi, N. Kandhukuri, S. Kondraganti, M. Gujrati, W. C. Olivero, D. H. Dinh, and J. S. Rao RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells Mol. Cancer Ther., December 1, 2006; 5(12): 3197 - 3208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stefanidakis and E. Koivunen Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression Blood, September 1, 2006; 108(5): 1441 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chaurasia, J. A. Aguirre-Ghiso, O. D. Liang, H. Gardsvoll, M. Ploug, and L. Ossowski A Region in Urokinase Plasminogen Receptor Domain III Controlling a Functional Association with {alpha}5beta1 Integrin and Tumor Growth J. Biol. Chem., May 26, 2006; 281(21): 14852 - 14863. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghosh, J. J. Johnson, R. Sen, S. Mukhopadhyay, Y. Liu, F. Zhang, Y. Wei, H. A. Chapman, and M. S. Stack Functional Relevance of Urinary-type Plasminogen Activator Receptor-{alpha}3beta1 Integrin Association in Proteinase Regulatory Pathways J. Biol. Chem., May 12, 2006; 281(19): 13021 - 13029. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Kwak, S. Mitra, K. Bdeir, D. Strassheim, J. S. Park, J. Y. Kim, S. Idell, D. Cines, and E. Abraham The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins J. Leukoc. Biol., October 1, 2005; 78(4): 937 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Bauer, W. Liu, F. Fan, E. R. Camp, A. Yang, R. J. Somcio, C. D. Bucana, J. Callahan, G. C. Parry, D. B. Evans, et al. Targeting of Urokinase Plasminogen Activator Receptor in Human Pancreatic Carcinoma Cells Inhibits c-Met- and Insulin-like Growth Factor-I Receptor-Mediated Migration and Invasion and Orthotopic Tumor Growth in Mice Cancer Res., September 1, 2005; 65(17): 7775 - 7781. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Degryse, M. Resnati, R.-P. Czekay, D. J. Loskutoff, and F. Blasi Domain 2 of the Urokinase Receptor Contains an Integrin-interacting Epitope with Intrinsic Signaling Activity: GENERATION OF A NEW INTEGRIN INHIBITOR J. Biol. Chem., July 1, 2005; 280(26): 24792 - 24803. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, R.-P. Czekay, L. Robillard, M. C. Kugler, F. Zhang, K. K. Kim, J.-p. Xiong, M. J. Humphries, and H. A. Chapman Regulation of {alpha}5{beta}1 integrin conformation and function by urokinase receptor binding J. Cell Biol., January 31, 2005; 168(3): 501 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Beauvais, B. J. Burbach, and A. C. Rapraeger The syndecan-1 ectodomain regulates {alpha}v{beta}3 integrin activity in human mammary carcinoma cells J. Cell Biol., October 11, 2004; 167(1): 171 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bernstein, R. S. Greenberg, L. Taliana, and S. K. Masur Urokinase Anchors uPAR to the Actin Cytoskeleton Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2967 - 2977. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mayasundari, N. A. Whittemore, E. H. Serpersu, and C. B. Peterson The Solution Structure of the N-terminal Domain of Human Vitronectin: PROXIMAL SITES THAT REGULATE FIBRINOLYSIS AND CELL MIGRATION J. Biol. Chem., July 9, 2004; 279(28): 29359 - 29366. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bjorklund, P. Heikkila, and E. Koivunen Peptide Inhibition of Catalytic and Noncatalytic Activities of Matrix Metalloproteinase-9 Blocks Tumor Cell Migration and Invasion J. Biol. Chem., July 9, 2004; 279(28): 29589 - 29597. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Noel, C Maillard, N Rocks, M Jost, V Chabottaux, N E Sounni, E Maquoi, D Cataldo, and J M Foidart Membrane associated proteases and their inhibitors in tumour angiogenesis J. Clin. Pathol., June 1, 2004; 57(6): 577 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Huang, A. L. Kindzelskii, A. J. Clark, and H. R. Petty Identification of Channels Promoting Calcium Spikes and Waves in HT1080 Tumor Cells: Their Apparent Roles in Cell Motility and Invasion Cancer Res., April 1, 2004; 64(7): 2482 - 2489. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Kanse, T. Chavakis, N. Al-Fakhri, K. Hersemeyer, D. Monard, and K. T. Preissner Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1 J. Cell Sci., January 22, 2004; 117(3): 477 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jo, K. S. Thomas, L. Wu, and S. L. Gonias Soluble Urokinase-type Plasminogen Activator Receptor Inhibits Cancer Cell Growth and Invasion by Direct Urokinase-independent Effects on Cell Signaling J. Biol. Chem., November 21, 2003; 278(47): 46692 - 46698. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bdeir, A. Kuo, B. S. Sachais, A. H. Rux, Y. Bdeir, A. Mazar, A. A.-R. Higazi, and D. B. Cines The kringle stabilizes urokinase binding to the urokinase receptor Blood, November 15, 2003; 102(10): 3600 - 3608. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tarui, N. Andronicos, R.-P. Czekay, A. P. Mazar, K. Bdeir, G. C. Parry, A. Kuo, D. J. Loskutoff, D. B. Cines, and Y. Takada Critical Role of Integrin {alpha}5{beta}1 in Urokinase (uPA)/Urokinase Receptor (uPAR, CD87) Signaling J. Biol. Chem., August 8, 2003; 278(32): 29863 - 29872. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vehvilainen, M. Hyytiainen, and J. Keski-Oja Latent Transforming Growth Factor-{beta}-binding Protein 2 Is an Adhesion Protein for Melanoma Cells J. Biol. Chem., June 27, 2003; 278(27): 24705 - 24713. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, P. Carmeliet, and A. A. Eddy Urokinase Receptor Modulates Cellular and Angiogenic Responses in Obstructive Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1234 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobayashi, M. Suzuki, Y. Tanaka, N. Kanayama, and T. Terao A Kunitz-type Protease Inhibitor, Bikunin, Inhibits Ovarian Cancer Cell Invasion by Blocking the Calcium-dependent Transforming Growth Factor-beta 1 Signaling Cascade J. Biol. Chem., February 28, 2003; 278(10): 7790 - 7799. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jo, K. S. Thomas, D. M. O'Donnell, and S. L. Gonias Epidermal Growth Factor Receptor-dependent and -independent Cell-signaling Pathways Originating from the Urokinase Receptor J. Biol. Chem., January 10, 2003; 278(3): 1642 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xia, G. Borland, J. Huang, I. F. Mizukami, H. R. Petty, R. F. Todd III, and G. D. Ross Function of the Lectin Domain of Mac-1/Complement Receptor Type 3 (CD11b/CD18) in Regulating Neutrophil Adhesion J. Immunol., December 1, 2002; 169(11): 6417 - 6426. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Montuori, M. V. Carriero, S. Salzano, G. Rossi, and P. Ragno The Cleavage of the Urokinase Receptor Regulates Its Multiple Functions J. Biol. Chem., November 27, 2002; 277(49): 46932 - 46939. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Leksa, S. Godar, M. Cebecauer, I. Hilgert, J. Breuss, U. H. Weidle, V. Horejsi, B. R. Binder, and H. Stockinger The N Terminus of Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor in Regulation of Fibrinolysis and Cell Migration J. Biol. Chem., October 18, 2002; 277(43): 40575 - 40582. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Besta, S. Massberg, K. Brand, E. Muller, S. Page, S. Gruner, M. Lorenz, K. Sadoul, W. Kolanus, E. Lengyel, et al. Role of {beta}3-endonexin in the regulation of NF-{kappa}B-dependent expression of urokinase-type plasminogen activator receptor J. Cell Sci., October 15, 2002; 115(20): 3879 - 3888. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Artym, A. L. Kindzelskii, W.-T. Chen, and H. R. Petty Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on {beta}1 integrins and the cytoskeleton Carcinogenesis, October 1, 2002; 23(10): 1593 - 1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Artym and H. R. Petty Molecular Proximity of Kv1.3 Voltage-gated Potassium Channels and {beta}1-Integrins on the Plasma Membrane of Melanoma Cells: Effects of Cell Adherence and Channel Blockers J. Gen. Physiol., June 10, 2002; 120(1): 29 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sturge, J. Hamelin, and G. E. Jones N-WASP activation by a {beta}1-integrin-dependent mechanism supports PI3K-independent chemotaxis stimulated by urokinase-type plasminogen activator J. Cell Sci., February 15, 2002; 115(4): 699 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, C. Baskerville, Q. Han, Z. K. Pan, and S. Huang alpha v Integrin, p38 Mitogen-activated Protein Kinase, and Urokinase Plasminogen Activator Are Functionally Linked in Invasive Breast Cancer Cells J. Biol. Chem., December 14, 2001; 276(51): 47901 - 47905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Gyetko, S. Sud, J. Sonstein, T. Polak, A. Sud, and J. L. Curtis Cutting Edge: Antigen-Driven Lymphocyte Recruitment to the Lung Is Diminished in the Absence of Urokinase-Type Plasminogen Activator (uPA) Receptor, but Is Independent of uPA J. Immunol., November 15, 2001; 167(10): 5539 - 5542. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, J. A. Eble, Z. Wang, J. A. Kreidberg, and H. A. Chapman Urokinase Receptors Promote beta 1 Integrin Function through Interactions with Integrin alpha 3beta 1 Mol. Biol. Cell, October 1, 2001; 12(10): 2975 - 2986. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. van der Pluijm, B. Sijmons, H. Vloedgraven, C. van der Bent, J.-W. Drijfhout, J. Verheijen, P. Quax, M. Karperien, S. Papapoulos, and C. Lowik Urokinase-Receptor/Integrin Complexes Are Functionally Involved in Adhesion and Progression of Human Breast Cancer in Vivo Am. J. Pathol., September 1, 2001; 159(3): 971 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-P. Czekay, T. A. Kuemmel, R. A. Orlando, and M. G. Farquhar Direct Binding of Occupied Urokinase Receptor (uPAR) to LDL Receptor-related Protein Is Required for Endocytosis of uPAR and Regulation of Cell Surface Urokinase Activity Mol. Biol. Cell, May 1, 2001; 12(5): 1467 - 1479. [Abstract] [Full Text] |
||||
![]() |
K. HORINO, A. L. KINDEZELSKII, V. M. ELNER, B. A. HUGHES, and H. R. PETTY Tumor cell invasion of model 3-dimensional matrices: demonstration of migratory pathways, collagen disruption, and intercellular cooperation FASEB J, April 1, 2001; 15(6): 932 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kjoller and A. Hall Rac Mediates Cytoskeletal Rearrangements and Increased Cell Motility Induced by Urokinase-Type Plasminogen Activator Receptor Binding to Vitronectin J. Cell Biol., March 19, 2001; 152(6): 1145 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hapke, M. Gawaz, K. Dehne, J. Köhler, J. F. Marshall, H. Graeff, M. Schmitt, U. Reuning, and E. Lengyel {beta}3A-Integrin Downregulates the Urokinase-Type Plasminogen Activator Receptor (u-PAR) through a PEA3/ets Transcriptional Silencing Element in the u-PAR Promoter Mol. Cell. Biol., March 15, 2001; 21(6): 2118 - 2132. [Abstract] [Full Text] |
||||
![]() |
B. Steffensen, L. Hakkinen, and H. Larjava Proteolytic Events of Wound-Healing -- Coordinated Interactions Among Matrix Metalloproteinases (MMPs), Integrins, and Extracellular Matrix Molecules Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(5): 373 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mazumdar, L. Adam, D. Boyd, and R. Kumar Heregulin Regulation of Urokinase Plasminogen Activator and its Receptor: Human Breast Epithelial Cell Invasion Cancer Res., January 1, 2001; 61(1): 400 - 405. [Abstract] [Full Text] |
||||
![]() |
R. G. Sitrin, P. M. Pan, H. A. Harper, R. F. Todd III, D. M. Harsh, and R. A. Blackwood Clustering of Urokinase Receptors (uPAR; CD87) Induces Proinflammatory Signaling in Human Polymorphonuclear Neutrophils J. Immunol., September 15, 2000; 165(6): 3341 - 3349. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W.Y. Wong, G. Wiedle, C. Ballestrem, B. Wehrle-Haller, S. Etteldorf, M. Bruckner, B. Engelhardt, R. H. Gisler, and B. A. Imhof PECAM-1/CD31 Trans-homophilic Binding at the Intercellular Junctions Is Independent of Its Cytoplasmic Domain; Evidence for Heterophilic Interaction with Integrin alpha vbeta 3 in Cis Mol. Biol. Cell, September 1, 2000; 11(9): 3109 - 3121. [Abstract] [Full Text] |
||||
![]() |
D. I. Simon, Y. Wei, L. Zhang, N. K. Rao, H. Xu, Z. Chen, Q. Liu, S. Rosenberg, and H. A. Chapman Identification of a Urokinase Receptor-Integrin Interaction Site. PROMISCUOUS REGULATOR OF INTEGRIN FUNCTION J. Biol. Chem., March 31, 2000; 275(14): 10228 - 10234. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Kindzelskii, Z.-y. Yang, G. J. Nabel, R. F. Todd III, and H. R. Petty Ebola Virus Secretory Glycoprotein (sGP) Diminishes Fc{gamma}RIIIB-to-CR3 Proximity on Neutrophils J. Immunol., January 15, 2000; 164(2): 953 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. A. Ghiso, K. Kovalski, and L. Ossowski Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling J. Cell Biol., October 4, 1999; 147(1): 89 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Carriero, S. D. Vecchio, M. Capozzoli, P. Franco, L. Fontana, A. Zannetti, G. Botti, G. D'Aiuto, M. Salvatore, and M. P. Stoppelli Urokinase Receptor Interacts with {{alpha}}v{{beta}}5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer Cancer Res., October 1, 1999; 59(20): 5307 - 5314. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Degryse, M. Resnati, S. A. Rabbani, A. Villa, F. Fazioli, and F. Blasi Src-Dependence and Pertussis-Toxin Sensitivity of Urokinase Receptor-Dependent Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells Blood, July 15, 1999; 94(2): 649 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H.D. Nguyen, A. D. Catling, D. J. Webb, M. Sankovic, L. A. Walker, A. V. Somlyo, M. J. Weber, and S. L. Gonias Myosin Light Chain Kinase Functions Downstream of Ras/ERK to Promote Migration of Urokinase-Type Plasminogen Activator-Stimulated Cells in an Integrin-Selective Manner J. Cell Biol., July 12, 1999; 146(1): 149 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mira, S. Mañes, R. A. Lacalle, G. Márquez, and C. Martínez-A Insulin-Like Growth Factor I-Triggered Cell Migration and Invasion Are Mediated by Matrix Metalloproteinase-9 Endocrinology, April 1, 1999; 140(4): 1657 - 1664. [Abstract] [Full Text] |
||||
![]() |
C. Liu, J. Yao, I. de Belle, R.-P. Huang, E. Adamson, and D. Mercola The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-beta 1, Fibronectin, and Plasminogen Activator Inhibitor-1 J. Biol. Chem., February 12, 1999; 274(7): 4400 - 4411. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Gardner, A Broberg, A Pozzi, M Laato, and J Heino Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis J. Cell Sci., January 2, 1999; 112(3): 263 - 272. [Abstract] [PDF] |
||||
![]() |
S Suzuki, Y Hayashi, Y Wang, T Nakamura, Y Morita, K Kawasaki, K Ohta, N Aoyama, S R Kim, H Itoh, et al. Urokinase type plasminogen activator receptor expression in colorectal neoplasms Gut, December 1, 1998; 43(6): 798 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Weerasinghe, K. P. McHugh, F. P. Ross, E. J. Brown, R. H. Gisler, and B. A. Imhof A Role for the {alpha}v{beta}3 Integrin in the Transmigration of Monocytes J. Cell Biol., July 27, 1998; 142(2): 595 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Shattil, H. Kashiwagi, and N. Pampori Integrin Signaling: The Platelet Paradigm Blood, April 15, 1998; 91(8): 2645 - 2657. [Full Text] [PDF] |
||||
![]() |
Y. Koshelnick, M. Ehart, P. Hufnagl, P. C. Heinrich, and B. R. Binder Urokinase Receptor Is Associated with the Components of the JAK1/STAT1 Signaling Pathway and Leads to Activation of This Pathway upon Receptor Clustering in the Human Kidney Epithelial Tumor Cell Line TCL-598 J. Biol. Chem., November 7, 1997; 272(45): 28563 - 28567. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghosh, R. Brown, J. C. R. Jones, S. M. Ellerbroek, and M. S. Stack Urinary-type Plasminogen Activator (uPA) Expression and uPA Receptor Localization Are Regulated by alpha 3beta 1 Integrin in Oral Keratinocytes J. Biol. Chem., July 28, 2000; 275(31): 23869 - 23876. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tarui, A. P. Mazar, D. B. Cines, and Y. Takada Urokinase-type Plasminogen Activator Receptor (CD87) Is a Ligand for Integrins and Mediates Cell-Cell Interaction J. Biol. Chem., February 2, 2001; 276(6): 3983 - 3990. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hapke, H. Kessler, N. A. de Prada, A. Benge, M. Schmitt, E. Lengyel, and U. Reuning Integrin alpha vbeta 3/Vitronectin Interaction Affects Expression of the Urokinase System in Human Ovarian Cancer Cells J. Biol. Chem., July 6, 2001; 276(28): 26340 - 26348. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mukhina, V. Stepanova, D. Traktouev, A. Poliakov, R. Beabealashvilly, Y. Gursky, M. Minashkin, A. Shevelev, and V. Tkachuk The Chemotactic Action of Urokinase on Smooth Muscle Cells Is Dependent on Its Kringle Domain. CHARACTERIZATION OF INTERACTIONS AND CONTRIBUTION TO CHEMOTAXIS J. Biol. Chem., May 26, 2000; 275(22): 16450 - 16458. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. D. Nguyen, D. J. Webb, A. D. Catling, Q. Song, A. Dhakephalkar, M. J. Weber, K. S. Ravichandran, and S. L. Gonias Urokinase-type Plasminogen Activator Stimulates the Ras/Extracellular Signal-regulated Kinase (ERK) Signaling Pathway and MCF-7 Cell Migration by a Mechanism That Requires Focal Adhesion Kinase, Src, and Shc. RAPID DISSOCIATION OF GRB2/SOS-SHC COMPLEX IS ASSOCIATED WITH THE TRANSIENT PHOSPHORYLATION OF ERK IN UROKINASE-TREATED CELLS J. Biol. Chem., June 16, 2000; 275(25): 19382 - 19388. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Woods and J. R. Couchman Integrin Modulation by Lateral Association J. Biol. Chem., August 4, 2000; 275(32): 24233 - 24236. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |